After giving multibagger returns, the stock has been consolidating for 11 months. A QIP was conducted in which many large, reputed institutions participated. No recommendation to buy or sell for now. We will observe the results. Only after that should one enter. The death of Mr. Rupen was unfortunate. The Q2 results will be crucial for this company to gauge its performance in the absence of Mr. Patel.